Global Dispersant Polymer Market

The polymer biomaterial market consists of sales of polymer biomaterial and related services by entities (organizations, sole traders, and partnerships) that produce polymer biomaterial used for enhancing the functionality of tissues and organs that are damaged in various disease therapies. Polymer biomaterials are inert pharmacological substances made up of natural and synthetic origin. The main types in the polymer biomaterial are silicone rubber, polyester, polymethyl methacrylate (PMMA), polyethylene (PE), polyvinyl chloride, and others. The silicon rubber in polymer biomaterials refers to the rubber matrix that is lightly cross-linked with a polyacrylamide hydrogel and is used for biological and medical purposes. The various nature includes natural and synthetic. The polymer biomaterials are used in cardiovascular, ophthalmology, dental, plastic surgery, wound healing, tissue engineering, orthopedics, neurological disorders / central nervous systems, and others. The global polymer biomaterial market size is expected to grow from $47.27 billion in 2021 to $55.96 billion in 2022 at a compound annual growth rate (CAGR) of 18.4%. The global polymer biomaterials market is expected to grow to $109.73 billion in 2026 at a CAGR of 18.3%. Increasing applications of polymeric biomaterials in tissue engineering are driving the global polymer biomaterials market. Polymers are extensively used in regenerative medicine and tissue engineering due to their flexibility and versatile properties such as tailoring the damaged tissue's physical, chemical, and mechanical properties by modification of functional groups during synthesis, according to the regeneration capability of tissues of the organs. Besides being biodegradable, they offer different geometry and structures, thus meeting the needs of specific tissue engineering applications. These growing applications of polymer biomaterial in tissue engineering are expected to drive the market in the forecast period. Stringent regulatory systems concerning the biocompatibility of polymer biomaterials are expected to limit the global polymer biomaterials market. Although biomaterials undergo rigorous premarket evaluations, considerable adverse events and complications are reported regarding the biocompatibility of polymer biomaterials. Biomaterial implantation may result in immunological and inflammatory reactions due to the induction of cellular and molecular events in the host, which may lead to excessive inflammation, impairment of healing, fibrotic encapsulation, tissue destruction, or even isolation and rejection of the implant. To overcome such adverse immune reactions, stringent regulations are imposed by the regulatory authorities, restricting the market growth. Companies in the polymer biomaterial market are increasingly investing in bioresorbable copolymers for medical devices for better performance and long-term stability. Companies such as Evonik have invested in bioresorbable polymers for use in implantable medical devices. The company's copolymer possesses hydrophobic properties of polylactide and hydrophilic properties of polyethylene glycol enabling the degradation rates up to six times faster with added mechanical strength. This innovation enhances biocompatibility, safety, and performance of implantable products, and is applied in the areas of pediatrics and wound closure to accelerate and ease the healing process and provide long-term stability. In January 2020, Mitsubishi Chemical Corporation completed the acquisition of AdvanSource Biomaterials Corporation for $7.25 million. This acquisition is expected to strengthen Mitsubishi’s position within the medical sector and drive its revenues. AdvanSource Biomaterials is a US-based company that manufactures polymer materials that provide critical characteristics in the design and development of medical devices. These polymer biomaterials are used in devices that are designed for treating a broad range of anatomical sites and disease states. Major players in the polymer biomaterials market are BASF, Corbion, Zimmer Biomet, Royal DSM, Koninklijke DSM, Covestro, Evonik Industries, Starch Medical, Victrex, and W. L. Gore and Associate. The regions covered in the global polymer biomaterial market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the polymer biomaterials market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA. The global polymer biomaterial market is segmented - 1) By Type: Nylon, Silicone Rubber, Polyester, Polymethyl Methacrylate (PMMA), Polyethylene (PE), Polyvinyl Chloride, Others 2) By Application: Cardiovascular, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Orthopedics, Neurological Disorders/ Central Nervous System, Others 3) By Nature: Natural, Synthetic

The paper products market consists of sales of plastics products by entities (organizations, sole traders and partnerships) that produce plastics products. The companies in this industry produce packaging materials, film and sheet, foam products, plastic bottles and all other plastic products which have domestic and industrial applications. These companies use polymers and resins as raw materials which are primarily sourced from polymer suppliers and processes used in plastic products manufacturing include compression molding, extrusion molding, injection molding, blow molding and casting. The main types of paper products are converted paper products, unfinished paper and pulp mills. The converted paper products industrial category consists mostly of companies that manufacture paper products from acquired paper and paperboard. Wood and agro residue, waste and recycled paper are used as raw material to produce paper products. The different applications include writing paper, magazine paper, packaging paper, sanitary paper and other. The global paper products market size is expected to grow from $890.44 billion in 2021 to $958.8 billion in 2022 at a compound annual growth rate (CAGR) of 7.7%. The paper products market is expected to grow to $1,234.22 billion in 2026 at a CAGR of 6.5%. The paper products manufacturing market is expected to benefit from steady economic growth forecasted for many developed and developing countries. According to the International Monetary Fund (IMF), the global GDP growth reached 3.3% in 2021 and 3.4% in 2021. Recovering commodity prices, after a decline in the historic period is further expected to be a significant factor driving economic growth. The US economy is expected to register stable growth during the forecast period. Additionally, emerging markets are expected to continue to grow slightly faster than the developed markets in the forecast period. Greater economic growth is likely to drive public and private investments, joint ventures, foreign direct investments in the end-user markets, thereby driving the market during forecast period. The outbreak of the Coronavirus disease (COVID-19) has acted as a massive restraint on the paper products manufacturing market in 2021 as supply chains were disrupted due to trade restrictions and consumption declined due to lockdowns imposed by governments globally. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty in breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People's Republic of China and spread globally including Western Europe, North America and Asia. Steps by national governments to contain the transmission have resulted in halting of manufacturing activities and a decline in economic activity with countries entering a state of lockdown and the outbreak had a negative impact on businesses throughout 2021 and into 2021. However, it is expected that the paper products manufacturing market will recover from the shock across the forecast period as it is a 'black swan' event and not related to ongoing or fundamental weaknesses in the market or the global economy. The paper industry has been shifting from labor intensive manufacturing processes to automated production facilities. Automation has enabled paper product companies to enhance productivity and reduce production costs. These technologies are also saving energy cost. Control systems such as integrated drive systems (IDS) are improving plant efficiency by minimizing energy consumption and simplifying service and maintenance processes. For instance, Swedish company Stora Enso partnered with Siemens to automate its Skoghall facility. Major companies in the paper products market include International Paper Company, Kimberly Clark Corporation, Procter & Gamble, WestRock Company, Essity AB, Oji Holdings Corporation, Smurfit Kappa Group PLC, Suzano Papel e Celulose S.A., Nine Dragons Paper (Holdings) Limited and DS Smith plc. Asia Pacific was the largest region in the paper products market in 2021. North America was the second largest region in the paper products market. The regions covered in the paper products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the paper products market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam. The global paper products market is segmented - 1) By Type: Converted Paper Products, Unfinished Paper, Pulp Mills 2) By Raw Material: Wood and Agro Residue, Waste and Recycled Paper 3) By Application: Writing Paper, Magazine Paper, Packaging Paper, Sanitary Paper, Others Subsegments Covered: Paperboard Container, Paper Bag and Coated and Treated Paper, Sanitary Paper Product, Stationery Products, All Other Converted Paper Products, Paper and Paperboard, Newsprint

The oil and gas market consists of sales of oil and gas by entities (organizations, sole traders or partnerships) that undertake the exploration for, extraction, drilling, and refining, of oil and gas and some of its derivatives. This market does not include petrochemicals. The main types are oil & gas upstream activities; oil downstream products. Oil and gas upstream activities include exploration activities, such as creating geological surveys and obtaining land rights and production activities, such as onshore and offshore drilling. The various drilling types include offshore; onshore that are used for residential, commercial, institutions and other applications. The global oil and gas market size is expected to grow from $6,098.98 billion in 2021 to $6,819.04 billion in 2022 at a compound annual growth rate (CAGR) of 11.8%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The oil and gas market is expected to reach $10,376.28 billion in 2026 at a CAGR of 11.1%. Low interest rates in most developed countries will positively impact the oil and gas industry during the forecast period. For instance, in 2019, the European Central Bank decreased interest rates to -0.5% on deposits from banks to encourage lending. This created a flow of cheap money for investment, both in developed and developing economies. It also encouraged borrowing and discouraged saving in advanced markets, helping to drive spending. Oil and gas companies were able to borrow more money for process improvements and expansion projects, thus driving the market during this period. Oil price volatility is likely to have a negative impact on the market as significant decline and increase in oil prices negatively impacts the government and consumer spending. The decline in oil prices is having a negative impact on government spending in countries such as Saudi Arabia, Nigeria and the UAE (United Arab Emirates) which are largely dependent on revenues generated through crude oil exports; whereas significant increase in oil prices had resulted in rising inflation, current account deficit and fiscal deficit in countries such as India and China, which predominantly import oil. For instance, the Saudi government is expected to cut down its spending from 1.05 trillion riyals ($280 billion) in 2019 to 1.02 trillion riyals ($270 billion) in 2020, to 955 billion riyals ($255 billion) by 2022, due to significant decline in revenues generated from oil exports, thereby affecting the market. This high volatility in oil prices is expected to negatively impact the market going forward. Major companies in the oil and gas industry are looking into big data analytics and artificial intelligence (AI) to enhance decisions making abilities and thus drive profits. The companies in this industry gather huge amounts of raw data relating to the working of refineries, pipelines and other infrastructure through a large number of sensors placed across the oil rig. Using big data analytics, the companies can detect patterns which can allow them to quickly react to unwanted changes or potential defects, thus saving costs. AI allows the companies to take better drilling and operational decisions. Companies such as ExxonMobil and Shell have been increasingly investing in AI technology to have a centralized method of data management and support data integration across multiple applications. Other companies such as Sinopec, a Chinese chemical and petroleum corporation, has announced its decision to construct 10 intelligent centers to help in reducing operation costs by 20%. Major companies in the oil and gas market include Royal Dutch Shell, BP plc, Saudi Aramco, Exxon Mobil, Gazprom PAO, Chevron, Iraq Ministry of Oil, PJSC Lukoil, Total SA, and Rosneft. Asia Pacific was the largest region in the oil and gas market in 2021. North America was the second largest region in the oil and gas market. The regions covered in the oil and gas market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the oil and gas market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam. The global oil and gas market is segmented - 1) By Type: Oil and Gas Upstream Activities, Oil Downstream Products 2) By Drilling Type: Offshore, Onshore 3) By Application: Residential, Commercial, Institutions, Others Subsegments Covered: Crude Oil, Natural Gas, Oil and Gas Wells Drilling Services, Oil and Gas Supporting Activities, Refined Petroleum Products, Asphalt, Lubricating Oil and Grease

The hydrocolloids market consists of sales of hydrocolloids by entities (organizations, sole traders, and partnerships) that refer to a substance that forms a gel in the presence of water. Hydrocolloids market are high-molecular-weight polysaccharides derived from plants and algae or synthesized by bacteria. A hydrocolloid is a particle dispersion in water made up of molecules that bind to the water and one another. The main types of products in hydrocolloids market are carrageenan, guar gum, gelatin, pectin, microcrystalline cellulose, and others. Carrageenan is a natural hydrocolloid that is derived from seaweeds. Their processing removes undesirable natural fibers and mucilage from the weed, and the result is a powder. The different functions include thickening, gelling, stabilizing, others and are extracted from various sources such as botanical, microbial, animal, seaweed, synthetic. It is used in several applications including food and beverages, pharmaceuticals, personal care products, and others. The global hydrocolloids market size is expected to grow from $9.10 billion in 2021 to $10.48 billion in 2022 at a compound annual growth rate (CAGR) of 15.2%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The hydrocolloid market is expected to reach $16.45 billion in 2026 at a CAGR of 11.9%. The increase in nutritionally aware consumers is expected to propel the growth of the hydrocolloids market during the forecast period. Consumers are preferring nutritional food as nutrition is critical for a multitude of reasons, including proper psychological well-being, muscle strength, pulmonary ventilation, infection prevention, wound healing, and cardiovascular function. Hydrocolloids are functional food ingredients that have great nutritional benefits and provide an opportunity to tailor nutritional value and offer potential health benefits by controlling gastric emptying and intestine brake mechanisms, glycemic response plasma cholesterol levels, and carbohydrate fermentation in the large intestine. For instance, according to the Kerry Group, an Ireland-based food company, in 2019, 65% of consumers seek nutritional benefits in their food and beverages. Therefore, the increase in nutritionally aware consumers drives the growth of the hydrocolloids market. The gellan gum is a key trend gaining popularity in the hydrocolloids market. Gellan gum is a water-soluble polysaccharide and multifunctional hydrocolloid commonly used as a gelling agent. It has properties of gelation, stabilization, texturizing, film-forming, thickening, structuring, and suspending agent and can be widely used in food and beverages, home care, personal care, and other industrial applications. Gellan gum is the most expensive form of hydrocolloid and is extensively used to improve food texture. For instance, in 2021, Jungbunzlauer, a Switzerland-based producer of natural biodegradable ingredients launched TayaGel, a high acyl Gellan gum. TayaGel is a highly functional hydrocolloid that has properties of excellent flavor release, suspending agent, thickening, and gelling agent. TayaGel HA is developed for all non-dairy products and TayaGel HA-D for dairy products. In February 2021, DuPont Nutrition and Biosciences, a Denmark-based nutrition company merged with International Flavors & Fragrances (IFF) for $26.2 billion. The partnership combines International Flavors & Fragrances (IFF) capabilities in food flavors and fragrances with DuPont's leading positions in enzymes, food protection, and probiotics. International Flavors & Fragrances is a US-based company that produces value-added ingredients such as hydrocolloids, flavors, and fragrances. Major players in the hydrocolloids market are Archer Daniels Midland Company, Ashland Global, Cargill Incorporated, CP Kelco, Darling Ingredients, DuPont Nutrition & Biosciences, Hispanagar S A, Ingredion Incorporated, Kerry Group, Koninklijke DSM N.V., Aquarev Industries, BASF, Fiberstar Inc., FMC Corporation, Jungbunzlauer Suisse AG, Lotus Gums & Chemicals, Palsgaard A/S, and Hawkins Watts. North America was the largest region in the hydrocolloids market in 2021. The regions covered in the hydrocolloid market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the hydrocolloids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The global hydrocolloids market is segmented - 1) By Type: Carrageenan, Guar Gum, Gelatin, Pectin, Microcrystalline Cellulose, Others 2) By Function: Thickening, Gelling, Stabilizing, Others 3) By Source: Botanical, Microbial, Animal, Seaweed, Synthetic 4) By Application: Food and Beverage, Pharmaceutical, Personal Care Products, Others

The pharmaceutical drug market consists of sales of goods and related services by entities (organizations, sole traders and partnerships) that produce and sell pharmaceutical drugs used to treat various diseases. This industry includes establishments that produce drugs such as cardiovascular drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs and other drugs used to treat cardiovascular diseases, rare genetic disorders, infections, metabolic disorders, cancers, respiratory diseases and others. The main types of pharmaceutical drugs are cardiovascular drugs, dermatology drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs, anti-infective drugs, metabolic disorders drugs, musculoskeletal disorders drugs, central nervous system drugs, oncology drugs, ophthalmology drugs and respiratory diseases drugs. Cardiovascular drugs are used to treat medical conditions associated with the heart or the circulatory system (blood vessels), such as arrhythmias, blood clots, coronary artery disease, high or low blood pressure, high cholesterol, heart failure, and stroke. The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores and others. The global pharmaceutical drugs market size is expected to grow from $ 1,075.97 billion in 2021 to $1,136.23 billion in 2022 at a compound annual growth rate (CAGR) of 5.6%. The growth in the pharmaceutical drug market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The pharmaceutical drugs market is expected to reach $1,635.128 billion in 2026 at a CAGR of 9.5%. The rise in sedentary jobs, busy lifestyles and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence rose by 57% globally, in the year 2020. China and India together had about 193.4 million diabetic patients in 2019 and India is expected to have about 101 million diabetic patients by 2030, thereby increasing the need for biologics drugs for diabetic patients. These factors are expected to increase the patient pool globally, thereby driving the pharmaceutical drugs market during the forecast period. Interest rates globally are forecasted to rise in most of the developing and developed economies, during the forecast period, this is expected to limit new investments in the pharmaceutical drug market. Most countries across the world are raising interest rates to control inflation and also to limit the flow of capital out of the country. This is likely to affect new investments in terms of expansion, research and development of new products. For instance, the US interest rates rose up to 3.5% by 2021. These factors are expected to have a negative impact on the pharmaceutical drug market as borrowing money becomes expensive, thereby affecting the pharmaceuticals market growth. Early Rx-to-OTC switch, or switching the product from prescription to non-prescription status, is a key trend in the dermatology drugs market. Traditionally, the Rx-to-OTC status conversion was generally observed at a phase nearing the patent expiry or after. However, forward-thinking companies are now looking at switching from Rx-to-OTC well in advance of the patent expiry of the drug. This helps the manufacturer to capitalize on the pharmaceutical drug market opportunities for the product. Early Rx-to-OTC switching also provides an additional benefit as a way to recover all the expenses incurred on the product by the company. For example, in 2020, FDA has switched three prescription drugs to OTC including Voltaren for arthritis pain, olopatadine hydrochloride 0.1% and 0.2% (Pataday Twice Daily Relief and Pataday Once Daily Relief) for temporary relief of itchy and red eyes due to pollen, ragweed and grass. Major companies in the pharmaceutical drugs market include Bristol-Myers Squibb, Sanofi S.A, Johnson & Johnson, Novartis AG, Bayer AG, Abbott Laboratories, GlaxosmithKline, AstraZenec, Merck & Co and CJ Corp. North America was the largest region in the pharmaceutical drugs market in 2021. The Middle East is expected to be the fargest growing region in the forecast period. The regions covered in the pharmaceutical drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pharmaceutical drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam. The global pharmaceutical drugs market is segmented - 1) By Type: Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorders Drugs, Musculoskeletal Disorders Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others 3) By Route of Administration: Oral, Parenteral, Others 4) By Drug Classification: Branded Drugs, Generic Drugs 5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs Subsegments Covered: Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs for Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic and Anti-Anginal Drugs), Acne Drugs, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases, Antacids, Antiulcerants, Vitamin and Minerals, Antiobesity, Antiemetics and Antinauseants, Antidiarrhoeals, Hormonal Contraceptives, Drugs for Benign Prostatic Hypertrophy, Drugs for Infertility, Drugs for Erectile Dysfunction, Drugs for Urinary Incontinence and Overactive Bladder, Drugs for Infections and Others, Drugs for Hormonal Replacement Therapy, Diuretics, Blood Products, Anemia and Other Blood Disorder Drugs, Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal), Anti Diabetics Drugs, Anti-Thyroid Drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism), Drugs for Rheumatoid Arthritis, Muscle Relaxants, Other Musculoskeletal Disorders Drugs, Analgesics, Anti-Parkinsons Drugs, Anesthetics, Anti-Epileptics, Other CNS Drugs, Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Cancer Drugs, Brain Tumor Drugs, Thyroid Cancer Drugs, Skin Cancer Drugs, Bladder Cancer Drugs, Cervical Cancer Drugs, Blood Cancer Drugs, Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma), Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy), Anti-Asthmatics and COPD Drugs, Cough and Cold Preparations

The hand sanitizer market consists of sales of sanitizers and their related service. Sanitizers are substances or liquids used for cleaning objects to get rid of harmful microorganisms including bacteria. These are products that combine disinfectant and detergent and are used to remove dirt, reduce or kill bacteria, and dissolve grease from the surface to at least 99.9%. The main types of hand sanitizers are quaternary ammonium compounds based, alcohol-based, tridosan based, and other types. An alcohol-based sanitizer is defined as a liquid containing alcohol at a certain minute level that is designed for applying to the hands for inactivating the microorganisms and suppressing their growth. The alcohol-based sanitizers usually contain ethanol, n-propanol, isopropanol, or a mixture of these. The various hand sanitizer products are gel, foam, liquid, and other products. The major distribution channels of hand sanitizers include online stores, pharmacy stores, departmental stores, and other distribution channels. The main end-use industries of hand sanitizers are hospitals, restaurants, schools, household purposes, and others end-users. The global hand sanitizers market size is expected to grow from $3.33 billion in 2021 to $3.62 billion in 2022 at a compound annual growth rate (CAGR) of 8.8%. The global hand sanitizers market size is expected to grow to $5.25 billion in 2026 at a CAGR of 9.7%. The coronavirus outbreak is a major driver for the growth of the sanitizers market during the period. Hygiene is an important part of safety against the protection of coronavirus and staying healthy. Therefore the demand for sanitizers has grown tremendously post the COVID-19 outbreak globally, since the outbreak of the virus in China as sanitizers are effective against coronavirus. Center for Disease Control (CDC) recommends the use of alcohol-based hand sanitizers with greater than 60% ethanol or 70% isopropanol, as the preferred form of hand hygiene in healthcare settings. According to the U.S. Food & Drug Administration, more than 1,500 additional manufacturers have registered with the agency to meet the increased demand for hand sanitizers. Hence, the COVID-19 outbreak coupled with growing concerns for hygiene is anticipated to escalate the demand for sanitizers during the year 2020 and in years to come ahead. Health hazards associated with occupational exposure to chemicals used in sanitizers manufacturing are expected to limit the growth of the sanitizers market. According to Reuters’s health news on chemicals sanitizers and disinfectants linked to thyroid cancer, the workers who are exposed to chemicals or biocides used in the production of sanitizers, disinfectants, and deodorizers are likely to diagnose with a 65% higher risk of thyroid cancer. Thus, the occupational risk of exposure to chemicals during the production of chemical-based Sanitizers is forecast to restrict the development of the Sanitizers market over the forecast period. The expansion of production capacities and revamp of companies to meet the higher demand for hand sanitizers is a major trend shaping the sanitizers industry. For instance, in March 2020, Bell International Laboratories, a vertically-integrated cosmetics manufacturer, announced the expansion of their production of alcohol-based hand Sanitizers (gels and sprays) and is expected to produce 22 million units in April. Moreover, companies such as Radio Khaitan and Bacardi, manufacturers of alcoholic drinks have turned into Sanitizer producers amid the COVID-19 outbreak. This step was taken for companies’ contributions during the coronavirus pandemic to meet the increasing demand for hand Sanitizers for health and hygiene. Therefore, increasing production capacities and companies entering into the production of hand Sanitizers is a key trend for the Sanitizers market’s growth. In March 2020, Agritek Holdings, Inc., a USA-based active investor, and operator in the legal cannabis sector announced the acquisition of Full Spectrum Biosciences Inc. including a new product line of RehabRx CBG infused hand Sanitizers. Full Spectrum Biosciences Inc.’s acquisition is expected to provide Agritek Holdings, Inc. with an additional revenue platform, as both companies together plan to launch hemp-based nutraceutical products for a growing consumer segment. With the COVID-19 outbreak, Full Spectrum Biosciences Inc. is to launch cannabinoid-infused, aloe-based hand Sanitizer products containing CBG or cannabigerol. Full Spectrum Biosciences Inc. is focused on IP formulation of premium brands and genetic mapping of cannabis strains. Major players in the hand sanitizers market are Reckitt Benckiser Group, The Himalaya Drug Company, Procter and Gamble, Gojo Industry Inc., Henkel Corporation, Unilever, Vi-Jon Laboratories Inc, Chattem Inc, Best Sanitizers Inc, and Kutol Products Company. Asia Pacific was the largest region in the hand sanitizers market in 2021. North America was the second-largest region in the global hand sanitizers market. The regions covered in the global hand sanitizers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the hand sanitizers market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The global hand sanitizers market is segmented - 1) By Type: Quartenary Ammonium Compounds Based, Alcohol Based, Tridosan Based, Other Types 2) By Product: Gel, Foam, Liquid, Other Products 3) By Distribution Channel: Online Store, Pharmacy Store, Departmental Store, Other Distribution Channels 4) By End User: Hospitals, Restaurants, Schools, Household Purpose, Other End Users

The soap and other detergents market consists of sales of soap and other detergents and related services for removing dirt from human skin, textiles, and other solid surfaces. Soap and detergents are chemical compounds that refer to surface-active agents in general. These products are made from animal fats or vegetable oil and are used to clean a solid surface. Surface-active agents are categorized into four groups: anionic detergents, cationic detergents, nonionic non-ionic detergents, and ampholytic. The main product types of soap and other detergents are laundry detergent, soap, dishwashing detergent, toothpaste, and other product types. Toothpaste is a paste for cleaning the teeth. The various applications are homecare detergents, industrial soap and detergent, homecare soaps, and other applications. The end users are body, clothing, and other end-users. The global soap and other detergents market size is expected to grow from $105.6 billion in 2021 to $116.36 billion in 2022 at a compound annual growth rate (CAGR) of 10.2%. The global soap and other detergents market size is expected to grow to $167.35 billion in 2026 at a CAGR of 9.5%. The introduction of innovative new products is a key factor leading to the growth of the soap and other detergent industries. Manufacturers continue to focus on innovative product development to meet the unmet needs of their customers. Companies are launching anti-allergy soaps and natural ingredients containing detergents that are widely adopted. For instance, in 2019, Unilever, a British-Dutch consumer goods company launched a new liquid detergent product under the brand Hindustan Unilever (HUL), 'Love Home and Planet', which is HUL's fifth fabric wash brand, thereby is driving the demand for the soap and other detergents market globally. Soap and other detergent providers globally faced an uncertain regulatory environment in the historic period. There are certain regulations governing reducing the release of toxic chemical substances into the atmosphere during the manufacturing process of soaps and detergents. For instance, according to the US code of federal regulations (40 CFR), regarding the safety of the environment (part 417) comply with manufacturers of soap and detergent, which thereby restraints the soap and other detergents market. With increasing water scarcity worldwide, soap and other detergent manufacturers are working continuously on creating opportunities for water-efficient laundry products. These water-efficient laundry products require less water for rinsing as these concentrated detergents contain chemicals with less water-dependent laundry ingredients. Furthermore, these products also cut down packaging and transportation cost for the manufacturers. In August 2019, Hindustan Unilever (HUL) launched an ongoing premiumization strategy in the laundry category with the brand 'Love & Care'. The new brand is produced for washing premium fabrics like silk, fine cotton, and others. Thereby, are driving the market of soap and other detergents in the forecast period. Major players in the soap and other detergents markets are Procter & Gamble, Ecolab Inc, Unilever plc, Henkel AG & Co KGaA, Church & Dwight Co. Inc, Colgate-Palmolive Company, Dial, Reckitt Benckiser Group plc, The Clorox Company, and Lion Corp. Asia Pacific was the largest region in the soap and other detergents market in 2021. Western Europe was the second-largest region in the global soap and other detergents market. The regions covered in the global soap and other detergents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the soap and other detergents market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The global soap and other detergents market is segmented - 1) By Product Type: Laundry Detergent, Soap, Dishwashing Detergent, Toothpaste, Other Product Types 2) By Application: Homecare Detergents, Industrial Soap and Detergent, Homecare Soaps, Other Applications 3) By End User: Body, Clothing, Other End Users

The paints and coatings market consists of the sales of paints and coating by entities (organizations, sole traders, or partnerships) that mix pigments, solvents, and binders into paints and other coatings, such as stains, varnishes, lacquers, enamels, shellacs, and water-repellent coatings for concrete and masonry, and/or produce allied paint products, such as putties, paint, and varnish removers, paintbrush cleaners, and frit. The main types of paints and coatings are water-borne coatings, solvent-based coatings, powder coatings, and other types of paints and coatings. A waterborne coating is an environmentally friendly surface treatment that is using water as a solvent to disperse the resin used to make the coating or paint. The types of resins are acrylic, polyurethanes, polyesters, epoxy, alkyd, and other types of resins. The performance range is commodity coating range, engineering coating range, and high-performance coating range. The applications involved are architectural, automotive, wood, packaging, aerospace, and other applications. The global paints and coatings market size is expected to grow from $211.9 billion in 2021 to $230.22 billion in 2022 at a compound annual growth rate (CAGR) of 8.6%. The global paints and coatings market size is expected to grow to $311.47 billion in 2026 at a CAGR of 7.8%. There is a rapid growth in the consumption of paints and coatings in many industries. Paints and coatings are widely used in the automotive, construction, and manufacturing industries. For instance, the global buildings construction market is expected to increase from $6.6 trillion in 2019 to $8.4 trillion in 2022. Similarly, the global transportation manufacturing market is expected to increase from $6 trillion in 2019 to $7.8 trillion in 2022. Decorative paints and coatings are widely used in buildings and construction whereas protective paints and coatings are linked closely to the automotive, major appliance, and industrial equipment industries. Therefore, growth in end-user industries is expected to drive the paints and coatings market during the forecast period. The outbreak of Coronavirus disease (COVID-19) has acted as a significant restraint on the paints and coatings market in 2020 as supply chains were disrupted due to trade restrictions and consumption declined due to lockdowns imposed by governments globally. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty in breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China, and spread globally including Western Europe, North America, and Asia. Steps by national governments to contain the transmission have resulted in a decline in economic activity with countries entering a state of 'lock down' and the outbreak had a negative impact on businesses throughout 2020 and into 2021. However, it is expected that the paints and coatings market will recover from the shock across the forecast period as it is a 'black swan event and not related to ongoing or fundamental weaknesses in the market or the global economy. Biocides are being used in paints to enhance their longevity and to maintain their quality. Biocide additives have been designed to protect paints from getting damaged during storage or to keep fungi and algae from growing on the applied paints. The market for biocides in paints will continue to grow due to the switch from solvent-based to water-based paints as they are not hazardous for human health and the environment, and minimize fungally and algae growth. However, the replacement of traditional biocides based on chlorine and formaldehyde with environmentally friendly biocides adds to the costs of paint production. For instance, some of the major companies using biocide in paint manufacturing include The Dow Chemical Company, Troy Corporation, BASF SE, Thor Group, and AkzoNobel N.V. Major companies in the paints and coatings market include Sherwin Williams Co, PPG Industries Inc, Akzo Nobel N.V, BASF SE, Nippon Paint Holdings Co ltd, Axalta Coating Systems Ltd, Kansai Paint Co. Ltd, Asian Paints Limited, RPM International Inc, and Arkema SA. Asia Pacific was the largest region in the paints and coatings market in 2021. Western Europe was the second-largest region in the global paints and coatings market. The regions covered in the global paints and coatings market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the paints and coatings market are Argentina, Australia, Austria, Bangladesh, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Iran, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, Ukraine, USA, and Vietnam. The global paints and coatings market is segmented - 1) By Type: Water Borne Coatings, Solvent Based Coatings, Powder Coatings, Other Paints and Coatings 2) By Application: Architectural, Automotive, Wood, Packaging, Aerospace, Other Applications 3) By Type of Resin: Acrylic, Polyurethanes, Polyesters, Epoxy, Alkyd, Other Type of Resins 4) By Performance Range: Commodity Coating Range, Engineering Coating Range, High-Performance Coating Range